$HTGM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HTG MOLECULAR DIAGNOSTICS, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HTG MOLECULAR DIAGNOSTICS, INC. Get notifications about new insider transactions in HTG MOLECULAR DIAGNOSTICS, INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | HTGM | HTG MOLECULAR DIAG ... | Lawson Byron | SVP/Chief Commercia ... | Payment of Exercise | F | 5.47 | 28 | 153 | 2,901 | 2.9 K to 2.9 K (-0.96 %) |
| Apr 02 2021 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Payment of Exercise | F | 5.47 | 37 | 202 | 7,734 | 7.8 K to 7.7 K (-0.48 %) |
| Apr 02 2021 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Payment of Exercise | F | 5.47 | 62 | 339 | 10,442 | 10.5 K to 10.4 K (-0.59 %) |
| Jan 04 2021 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Payment of Exercise | F | 4.79 | 31 | 148 | 7,771 | 7.8 K to 7.8 K (-0.40 %) |
| Jan 04 2021 | HTGM | HTG MOLECULAR DIAG ... | Lawson Byron | SVP/Chief Commercia ... | Payment of Exercise | F | 4.79 | 24 | 115 | 2,929 | 3 K to 2.9 K (-0.81 %) |
| Jan 04 2021 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Payment of Exercise | F | 4.79 | 62 | 297 | 10,504 | 10.6 K to 10.5 K (-0.59 %) |
| Jan 04 2021 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Executive Chairman | Payment of Exercise | F | 4.79 | 109 | 522 | 16,738 | 16.8 K to 16.7 K (-0.65 %) |
| Dec 16 2020 | HTGM | HTG MOLECULAR DIAG ... | Godlewski Laura Lee | VP Finance, Prin Ac ... | Grant | A | 4.87 | 66 | 321 | 1,232 | 1.2 K to 1.2 K (+5.66 %) |
| Dec 16 2020 | HTGM | HTG MOLECULAR DIAG ... | Lawson Byron | SVP/Chief Commercia ... | Grant | A | 4.87 | 66 | 321 | 2,953 | 2.9 K to 3 K (+2.29 %) |
| Dec 16 2020 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Grant | A | 4.87 | 66 | 321 | 7,802 | 7.7 K to 7.8 K (+0.85 %) |
| Dec 16 2020 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Grant | A | 4.87 | 66 | 321 | 10,566 | 10.5 K to 10.6 K (+0.63 %) |
| Dec 16 2020 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Executive Chairman | Grant | A | 4.87 | 34 | 166 | 16,847 | 16.8 K to 16.8 K (+0.20 %) |
| Oct 02 2020 | HTGM | HTG MOLECULAR DIAG ... | Lawson Byron | SVP/Chief Commercia ... | Payment of Exercise | F | 0.33 | 350 | 116 | 43,333 | 43.7 K to 43.3 K (-0.80 %) |
| Oct 02 2020 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Payment of Exercise | F | 0.33 | 461 | 152 | 116,080 | 116.5 K to 116.1 K (-0.40 %) |
| Oct 02 2020 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Payment of Exercise | F | 0.33 | 921 | 304 | 157,534 | 158.5 K to 157.5 K (-0.58 %) |
| Oct 02 2020 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Executive Chairman | Payment of Exercise | F | 0.33 | 1,630 | 538 | 252,217 | 253.8 K to 252.2 K (-0.64 %) |
| Aug 24 2020 | HTGM | HTG MOLECULAR DIAG ... | Godlewski Laura Lee | VP Finance, Prin Ac ... | Option Exercise | A | 0.48 | 225,000 | 108,000 | 225,000 | |
| Aug 24 2020 | HTGM | HTG MOLECULAR DIAG ... | Lawson Byron | SVP/Chief Commercia ... | Option Exercise | A | 0.48 | 270,000 | 129,600 | 270,000 | |
| Aug 24 2020 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Option Exercise | A | 0.48 | 500,000 | 240,000 | 500,000 | |
| Aug 24 2020 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Executive Chairman | Option Exercise | A | 0.48 | 60,000 | 28,800 | 60,000 | |
| Aug 24 2020 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Option Exercise | A | 0.48 | 1,200,000 | 576,000 | 1,200,000 | |
| Aug 21 2020 | HTGM | HTG MOLECULAR DIAG ... | LAFRANCE JAMES T | Director | Option Exercise | A | 0.46 | 60,000 | 27,600 | 60,000 | |
| Aug 21 2020 | HTGM | HTG MOLECULAR DIAG ... | McCracken Lee R. | Director | Option Exercise | A | 0.46 | 60,000 | 27,600 | 60,000 | |
| Aug 21 2020 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Option Exercise | A | 0.46 | 60,000 | 27,600 | 60,000 | |
| Aug 21 2020 | HTGM | HTG MOLECULAR DIAG ... | HARDISON DON M | Director | Option Exercise | A | 0.46 | 60,000 | 27,600 | 60,000 | |
| Aug 21 2020 | HTGM | HTG MOLECULAR DIAG ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 0.46 | 60,000 | 27,600 | 60,000 | |
| Aug 21 2020 | HTGM | HTG MOLECULAR DIAG ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 0.46 | 60,000 | 27,600 | 60,000 | |
| Aug 21 2020 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Option Exercise | A | 0.46 | 60,000 | 27,600 | 60,000 | |
| Aug 21 2020 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Option Exercise | A | 0.46 | 60,000 | 27,600 | 60,000 | |
| Jul 02 2020 | HTGM | HTG MOLECULAR DIAG ... | Lawson Byron | SVP/Chief Commercia ... | Payment of Exercise | F | 0.72 | 350 | 252 | 43,683 | 44 K to 43.7 K (-0.79 %) |
| Jul 02 2020 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Payment of Exercise | F | 0.72 | 447 | 322 | 116,541 | 117 K to 116.5 K (-0.38 %) |
| Jul 02 2020 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Executive Chairman | Payment of Exercise | F | 0.72 | 1,630 | 1,174 | 253,847 | 255.5 K to 253.8 K (-0.64 %) |
| Jun 15 2020 | HTGM | HTG MOLECULAR DIAG ... | Lawson Byron | SVP/Chief Commercia ... | Grant | A | 0.55 | 1,000 | 553 | 44,033 | 43 K to 44 K (+2.32 %) |
| Jun 15 2020 | HTGM | HTG MOLECULAR DIAG ... | Godlewski Laura Lee | VP Finance, Prin Ac ... | Grant | A | 0.55 | 1,000 | 553 | 17,506 | 16.5 K to 17.5 K (+6.06 %) |
| Jun 15 2020 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Grant | A | 0.55 | 1,000 | 553 | 116,988 | 116 K to 117 K (+0.86 %) |
| Jun 15 2020 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Executive Chairman | Grant | A | 0.55 | 905 | 500 | 255,477 | 254.6 K to 255.5 K (+0.36 %) |
| Jun 15 2020 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Executive Chairman | Grant | A | 0.57 | 701 | 396 | 254,572 | 253.9 K to 254.6 K (+0.28 %) |
| Jun 15 2020 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Executive Chairman | Grant | A | 1.57 | 761 | 1,197 | 253,871 | 253.1 K to 253.9 K (+0.30 %) |
| Jun 15 2020 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Grant | A | 0.55 | 1,000 | 553 | 159,376 | 158.4 K to 159.4 K (+0.63 %) |
| Apr 02 2020 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Executive Chairman | Payment of Exercise | F | 0.33 | 1,630 | 538 | 253,110 | 254.7 K to 253.1 K (-0.64 %) |
| Apr 02 2020 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Payment of Exercise | F | 0.33 | 1,086 | 358 | 158,376 | 159.5 K to 158.4 K (-0.68 %) |
| Jan 27 2020 | HTGM | HTG MOLECULAR DIAG ... | Godlewski Laura Lee | VP Finance, Prin Ac ... | Option Exercise | A | 0.66 | 35,000 | 23,100 | 35,000 | |
| Jan 27 2020 | HTGM | HTG MOLECULAR DIAG ... | Godlewski Laura Lee | VP Finance, Prin Ac ... | Option Exercise | A | 0.66 | 35,000 | 23,100 | 35,000 | |
| Jan 27 2020 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Option Exercise | A | 0.66 | 237,500 | 156,750 | 237,500 | |
| Jan 27 2020 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Option Exercise | A | 0.66 | 237,500 | 156,750 | 237,500 | |
| Jan 27 2020 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Option Exercise | A | 0.66 | 537,500 | 354,750 | 537,500 | |
| Jan 27 2020 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Option Exercise | A | 0.66 | 537,500 | 354,750 | 537,500 | |
| Jan 02 2020 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Executive Chairman | Payment of Exercise | F | 0.70 | 1,381 | 967 | 254,740 | 256.1 K to 254.7 K (-0.54 %) |
| Jan 02 2020 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Executive Chairman | Sell | S | 0.72 | 5,718 | 4,110 | 256,121 | 261.8 K to 256.1 K (-2.18 %) |
| Jan 02 2020 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Payment of Exercise | F | 0.70 | 461 | 323 | 116,532 | 117 K to 116.5 K (-0.39 %) |
| Jan 02 2020 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Payment of Exercise | F | 0.70 | 921 | 645 | 159,462 | 160.4 K to 159.5 K (-0.57 %) |
| Jan 02 2020 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Executive Chairman | Payment of Exercise | F | 0.70 | 1,381 | 967 | 254,740 | 256.1 K to 254.7 K (-0.54 %) |
| Jan 02 2020 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Executive Chairman | Sell | S | 0.72 | 5,718 | 4,110 | 256,121 | 261.8 K to 256.1 K (-2.18 %) |
| Jan 02 2020 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Payment of Exercise | F | 0.70 | 461 | 323 | 116,532 | 117 K to 116.5 K (-0.39 %) |
| Jan 02 2020 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Payment of Exercise | F | 0.70 | 921 | 645 | 159,462 | 160.4 K to 159.5 K (-0.57 %) |
| Dec 12 2019 | HTGM | HTG MOLECULAR DIAG ... | Godlewski Laura Lee | VP Finance, Prin Ac ... | Grant | A | 0.57 | 701 | 396 | 16,506 | 15.8 K to 16.5 K (+4.44 %) |
| Dec 12 2019 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Grant | A | 0.57 | 701 | 396 | 116,993 | 116.3 K to 117 K (+0.60 %) |
| Dec 12 2019 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Grant | A | 0.57 | 701 | 396 | 160,383 | 159.7 K to 160.4 K (+0.44 %) |
| Nov 18 2019 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Executive Chairman | Option Exercise | A | 0.68 | 35,000 | 23,800 | 35,000 | |
| Oct 02 2019 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Payment of Exercise | F | 0.66 | 921 | 608 | 159,682 | 160.6 K to 159.7 K (-0.57 %) |
| Oct 02 2019 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Executive Chairman | Payment of Exercise | F | 0.66 | 1,381 | 911 | 261,839 | 263.2 K to 261.8 K (-0.52 %) |
| Sep 16 2019 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Director | Option Exercise | A | 0.78 | 15,000 | 11,700 | 15,000 | |
| Sep 16 2019 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Director | Option Exercise | A | 0.78 | 15,000 | 11,700 | 15,000 | |
| Sep 16 2019 | HTGM | HTG MOLECULAR DIAG ... | Godlewski Laura Lee | VP Finance, Prin Ac ... | Option Exercise | A | 0.78 | 15,000 | 11,700 | 15,000 | |
| Aug 19 2019 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Option Exercise | A | 0.95 | 47,500 | 45,125 | 47,500 | |
| Aug 19 2019 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Option Exercise | A | 0.95 | 112,500 | 106,875 | 112,500 | |
| Aug 19 2019 | HTGM | HTG MOLECULAR DIAG ... | Godlewski Laura Lee | VP Finance, Prin Ac ... | Option Exercise | A | 0.95 | 30,000 | 28,500 | 30,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | GRIFFIN MICHELLE RENEE | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | McCracken Lee R. | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | McCracken Lee R. | Director | Grant | A | 0.00 | 2,500 | 0 | 5,000 | 2.5 K to 5 K (+100.00 %) |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | HARDISON DON M | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | HARDISON DON M | Director | Grant | A | 0.00 | 2,500 | 0 | 12,500 | 10 K to 12.5 K (+25.00 %) |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Grant | A | 0.00 | 2,500 | 0 | 39,030 | 36.5 K to 39 K (+6.84 %) |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Grant | A | 0.00 | 2,500 | 0 | 7,304 | 4.8 K to 7.3 K (+52.04 %) |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | LAFRANCE JAMES T | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | LAFRANCE JAMES T | Director | Grant | A | 0.00 | 2,500 | 0 | 12,500 | 10 K to 12.5 K (+25.00 %) |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | GRIFFIN MICHELLE RENEE | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | McCracken Lee R. | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | McCracken Lee R. | Director | Grant | A | 0.00 | 2,500 | 0 | 5,000 | 2.5 K to 5 K (+100.00 %) |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | HARDISON DON M | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | HARDISON DON M | Director | Grant | A | 0.00 | 2,500 | 0 | 12,500 | 10 K to 12.5 K (+25.00 %) |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Grant | A | 0.00 | 2,500 | 0 | 39,030 | 36.5 K to 39 K (+6.84 %) |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Grant | A | 0.00 | 2,500 | 0 | 7,304 | 4.8 K to 7.3 K (+52.04 %) |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | LAFRANCE JAMES T | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | LAFRANCE JAMES T | Director | Grant | A | 0.00 | 2,500 | 0 | 12,500 | 10 K to 12.5 K (+25.00 %) |
| Jul 03 2019 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Payment of Exercise | F | 1.66 | 461 | 765 | 116,753 | 117.2 K to 116.8 K (-0.39 %) |
| Jul 03 2019 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Payment of Exercise | F | 1.66 | 921 | 1,529 | 160,603 | 161.5 K to 160.6 K (-0.57 %) |
| Jul 03 2019 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Director | Payment of Exercise | F | 1.66 | 1,381 | 2,292 | 263,220 | 264.6 K to 263.2 K (-0.52 %) |
| Jun 13 2019 | HTGM | HTG MOLECULAR DIAG ... | Godlewski Laura Lee | VP of Accounting an ... | Grant | A | 1.57 | 761 | 1,197 | 15,805 | 15 K to 15.8 K (+5.06 %) |
| Jun 13 2019 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Grant | A | 1.57 | 761 | 1,197 | 117,214 | 116.5 K to 117.2 K (+0.65 %) |
| Jun 13 2019 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Grant | A | 1.57 | 761 | 1,197 | 161,524 | 160.8 K to 161.5 K (+0.47 %) |
| May 29 2019 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Director | Grant | A | 2.30 | 7,500 | 17,250 | 264,601 | 257.1 K to 264.6 K (+2.92 %) |
| May 29 2019 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Director | Grant | A | 2.30 | 7,500 | 17,250 | 264,601 | 257.1 K to 264.6 K (+2.92 %) |
| May 24 2019 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Option Exercise | A | 2.22 | 300,000 | 666,000 | 300,000 | |
| Apr 01 2019 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Payment of Exercise | F | 2.50 | 447 | 1,118 | 116,453 | 116.9 K to 116.5 K (-0.38 %) |
| Apr 01 2019 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | Director | Payment of Exercise | F | 2.50 | 1,381 | 3,453 | 257,101 | 258.5 K to 257.1 K (-0.53 %) |
| Apr 01 2019 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Payment of Exercise | F | 2.50 | 909 | 2,273 | 160,763 | 161.7 K to 160.8 K (-0.56 %) |
| Jan 02 2019 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Payment of Exercise | F | 2.54 | 461 | 1,171 | 116,900 | 117.4 K to 116.9 K (-0.39 %) |
| Jan 02 2019 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & COO | Payment of Exercise | F | 2.54 | 921 | 2,339 | 161,672 | 162.6 K to 161.7 K (-0.57 %) |
| Jan 02 2019 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | CEO | Payment of Exercise | F | 2.54 | 1,381 | 3,508 | 258,482 | 259.9 K to 258.5 K (-0.53 %) |
| Dec 17 2018 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Buy | J | 1.57 | 735 | 1,156 | 117,361 | 116.6 K to 117.4 K (+0.63 %) |
| Dec 17 2018 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & COO | Buy | J | 1.57 | 735 | 1,156 | 162,593 | 161.9 K to 162.6 K (+0.45 %) |
| Dec 17 2018 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | CEO | Buy | J | 1.57 | 735 | 1,156 | 259,863 | 259.1 K to 259.9 K (+0.28 %) |
| Oct 02 2018 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | CEO | Payment of Exercise | F | 4.52 | 1,381 | 6,242 | 259,128 | 260.5 K to 259.1 K (-0.53 %) |
| Oct 02 2018 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & COO | Payment of Exercise | F | 4.52 | 921 | 4,163 | 161,858 | 162.8 K to 161.9 K (-0.57 %) |
| Oct 02 2018 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Payment of Exercise | F | 4.52 | 461 | 2,084 | 116,626 | 117.1 K to 116.6 K (-0.39 %) |
| Sep 12 2018 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Grant | A | 4.34 | 2,304 | 9,999 | 4,804 | 2.5 K to 4.8 K (+92.16 %) |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Option Exercise | A | 3.40 | 100,000 | 340,000 | 100,000 | |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Grant | A | 0.00 | 25,000 | 0 | 117,087 | 92.1 K to 117.1 K (+27.15 %) |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & COO | Option Exercise | A | 3.40 | 100,000 | 340,000 | 100,000 | |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & COO | Grant | A | 0.00 | 50,000 | 0 | 162,779 | 112.8 K to 162.8 K (+44.33 %) |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | CEO | Option Exercise | A | 3.40 | 150,000 | 510,000 | 150,000 | |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | CEO | Grant | A | 0.00 | 75,000 | 0 | 260,509 | 185.5 K to 260.5 K (+40.43 %) |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | LAFRANCE JAMES T | Director | Option Exercise | A | 3.31 | 10,000 | 33,100 | 10,000 | |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | LAFRANCE JAMES T | Director | Grant | A | 0.00 | 2,500 | 0 | 10,000 | 7.5 K to 10 K (+33.33 %) |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | McCracken Lee R. | Director | Option Exercise | A | 3.31 | 10,000 | 33,100 | 10,000 | |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | McCracken Lee R. | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | HARDISON DON M | Director | Option Exercise | A | 3.31 | 10,000 | 33,100 | 10,000 | |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | HARDISON DON M | Director | Grant | A | 0.00 | 2,500 | 0 | 10,000 | 7.5 K to 10 K (+33.33 %) |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Option Exercise | A | 3.31 | 10,000 | 33,100 | 10,000 | |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Grant | A | 0.00 | 2,500 | 0 | 36,530 | 34 K to 36.5 K (+7.35 %) |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Option Exercise | A | 3.31 | 10,000 | 33,100 | 10,000 | |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 3.31 | 20,000 | 66,200 | 20,000 | |
| Jun 14 2018 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & COO | Buy | J | 1.57 | 788 | 1,239 | 112,779 | 112 K to 112.8 K (+0.70 %) |
| Jun 14 2018 | HTGM | HTG MOLECULAR DIAG ... | Roche Patrick C. | SVP Medical/Scienti ... | Buy | J | 1.57 | 788 | 1,239 | 43,421 | 42.6 K to 43.4 K (+1.85 %) |
| Jun 14 2018 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | CEO | Buy | J | 1.57 | 788 | 1,239 | 185,509 | 184.7 K to 185.5 K (+0.43 %) |
| Jun 14 2018 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Buy | J | 1.57 | 675 | 1,061 | 92,087 | 91.4 K to 92.1 K (+0.74 %) |
| Jan 31 2018 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | SVP, Finance & Admi ... | Grant | A | 0.00 | 48,291 | 0 | 91,412 | 43.1 K to 91.4 K (+111.99 %) |
| Jan 31 2018 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | SVP, Chief Business ... | Grant | A | 0.00 | 63,483 | 0 | 111,991 | 48.5 K to 112 K (+130.87 %) |
| Jan 31 2018 | HTGM | HTG MOLECULAR DIAG ... | Gordon Debra A | SVP, Chief Legal Co ... | Grant | A | 0.00 | 29,719 | 0 | 72,552 | 42.8 K to 72.6 K (+69.38 %) |
| Jan 31 2018 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | President & CEO | Payment of Exercise | F | 3.84 | 34,769 | 133,513 | 184,721 | 219.5 K to 184.7 K (-15.84 %) |
| Jan 31 2018 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | President & CEO | Grant | A | 0.00 | 118,058 | 0 | 219,490 | 101.4 K to 219.5 K (+116.39 %) |
| Dec 15 2017 | HTGM | HTG MOLECULAR DIAG ... | Roche Patrick C. | SVP Research & Deve ... | Buy | J | 1.61 | 818 | 1,314 | 42,633 | 41.8 K to 42.6 K (+1.96 %) |
| Dec 15 2017 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | President & CEO | Buy | J | 1.61 | 818 | 1,314 | 101,432 | 100.6 K to 101.4 K (+0.81 %) |
| Dec 15 2017 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Buy | J | 1.61 | 818 | 1,314 | 48,508 | 47.7 K to 48.5 K (+1.72 %) |
| Dec 15 2017 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | VP, Finance & Admin ... | Buy | J | 1.61 | 818 | 1,314 | 43,121 | 42.3 K to 43.1 K (+1.93 %) |
| Dec 15 2017 | HTGM | HTG MOLECULAR DIAG ... | Gordon Debra A | V.P. and Chief Lega ... | Buy | J | 1.61 | 818 | 1,314 | 42,833 | 42 K to 42.8 K (+1.95 %) |
| Dec 01 2017 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | VP, Finance & Admin ... | Sell | S | 2.11 | 945 | 1,992 | 42,303 | 43.2 K to 42.3 K (-2.19 %) |
| Nov 30 2017 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Grant | A | 2.14 | 4,030 | 8,624 | 34,030 | 30 K to 34 K (+13.43 %) |
| Nov 27 2017 | HTGM | HTG MOLECULAR DIAG ... | Gordon Debra A | V.P. and Chief Lega ... | Grant | A | 2.25 | 1,111 | 2,500 | 42,015 | 40.9 K to 42 K (+2.72 %) |
| Nov 27 2017 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Grant | A | 2.20 | 7,500 | 16,500 | 15,000 | 7.5 K to 15 K (+100.00 %) |
| Nov 27 2017 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Grant | A | 2.25 | 7,500 | 16,875 | 7,500 | 0 to 7.5 K |
| Nov 07 2017 | HTGM | HTG MOLECULAR DIAG ... | QIAGEN NV | 10% Owner | Option Exercise | P | 3.98 | 753,012 | 3,000,000 | 753,012 |